Business Context and Reporting Period
This Form 6-K filing by Banco Santander (Brasil) S.A. covers the month of December 2025. The document serves as a notice to shareholders regarding the Board of Directors' approval of Interest on Equity (JCP) distributions for the fiscal year 2025.
Key Financial Metrics
The filing details specific capital distribution metrics rather than operational performance data such as revenue or net income.
- Total Interest on Equity (Gross): R$ 620,000,000.00
- Total Interest on Equity (Net after IRRF): R$ 527,000,000.00
- Per Share Distribution (ON - Common): R$ 0.07910367789 (Gross) / R$ 0.06723812621 (Net)
- Per Share Distribution (PN - Preferred): R$ 0.08701404568 (Gross) / R$ 0.07396193882 (Net)
- Per Unit Distribution (1 ON + 1 PN): R$ 0.16611772357 (Gross) / R$ 0.14120006503 (Net)
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing does not contain comparative financial data or material changes versus prior periods. It solely announces the current distribution decision.
Guidance, Outlook, and Management Commentary
Distribution Details: The approved Interest on Equity is subject to shareholder ratification at the Ordinary General Meeting in 2026. The payment is scheduled for February 5, 2026.
Dividend Treatment: The amount will be fully considered within the mandatory dividends to be distributed for the year 2025, with no monetary indexation compensation.
Trading Status: Shares will trade "Ex-Interest on Equity" starting January 5, 2026. The record date for entitlement is January 2, 2026.
ADRs: Payments for American Depositary Receipts (ADRs) will be handled by The Bank of New York Mellon in accordance with local market regulations.
Investor Verification Checklist
- Verify the final ratification of the Interest on Equity at the Ordinary General Meeting scheduled for 2026.
- Confirm the exact payment date of February 5, 2026, for both local shares and ADRs.
- Check the "Ex-Interest on Equity" trading status effective January 5, 2026, to ensure proper record date eligibility.
- Review the specific tax withholding implications for non-immune shareholders based on the net amounts provided.